Are you a bio/pharma company looking for compliant data systems that can be deployed rapidly to support accelerated manufacturing programs?
The pandemic has brought the vital importance of biotech and pharmaceutical development and manufacturing into sharp focus. The industry’s race to develop vaccines and therapeutic treatments has resulted in quick wins and the rapid development of proofs of concept. But how does this warp-speed go-to-market experience and the adoption of modern technologies shape future delivery of new medicines?
Learn how Novavax Director of Data and Analytics, Kyle Langham, leverages Skyland PIMS process information management system to advance process analytics and reporting across a complex supply chain to accelerate delivery of their COVID-19 vaccine candidate.
- Key Drivers for PIMS Adoption
- Selection Process & Requirements
- CMO Data Sharing Practices & Expectations
- Data Harmonization – Lessons Learned
- Technology Drives Competitive Advantage
